Stockscreener 앱 받기
9.88
1.60%
-0.13
전일 마감가:
$10.01
열려 있는:
$10.02
하루 거래량:
40,082
Relative Volume:
0.10
시가총액:
$402.03M
수익:
$825.37M
순이익/손실:
$-60.01M
주가수익비율:
-6.5775
EPS:
-1.5021
순현금흐름:
$-4.46M
1주 성능:
-4.74%
1개월 성능:
-15.31%
6개월 성능:
-28.98%
1년 성능:
-32.30%
1일 변동 폭
$9.795
$10.02
1주일 범위
$9.795
$10.74
52주 변동 폭
$8.85
$16.99
Orthofix Medical Inc Stock (OFIX) Company Profile
명칭
Orthofix Medical Inc
전화
214-937-2000
주소
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OFIX
Orthofix Medical Inc
|
9.87 | 426.88M | 825.37M | -60.01M | -4.46M | -1.5021 |
ABT
Abbott Laboratories
|
115.73 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.00 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.61 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.87 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.91 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | TD Cowen | Hold |
| 2025-10-28 | 재개 | Stifel | Buy |
| 2025-01-22 | 개시 | Canaccord Genuity | Buy |
| 2024-11-08 | 업그레이드 | Stifel | Hold → Buy |
| 2024-05-08 | 업그레이드 | ROTH MKM | Neutral → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-09-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-09-12 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-07-19 | 재개 | BTIG Research | Buy |
| 2022-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2020-10-20 | 개시 | Stifel | Hold |
| 2019-10-29 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-06-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-06-21 | 개시 | BTIG Research | Buy |
| 2017-06-14 | 개시 | Ladenburg Thalmann | Buy |
| 2017-05-23 | 개시 | SunTrust | Buy |
| 2015-07-10 | 개시 | Sidoti | Buy |
| 2013-05-09 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2013-01-08 | 재확인 | Mizuho | Buy |
| 2010-06-21 | 개시 | Boenning & Scattergood | Outperform |
| 2010-03-09 | 재확인 | Jefferies & Co | Buy |
| 2010-02-18 | 업그레이드 | Susquehanna Financial | Neutral → Positive |
| 2010-01-22 | 개시 | Jefferies & Co | Buy |
| 2009-11-03 | 업그레이드 | Wells Fargo | Underperform → Market Perform |
| 2009-07-31 | 재확인 | Jefferies & Co | Buy |
| 2009-07-31 | 업그레이드 | Thomas Weisel | Market Weight → Overweight |
| 2009-05-26 | 재확인 | Jefferies & Co | Buy |
| 2009-04-17 | 다운그레이드 | Wachovia | Mkt Perform → Underperform |
| 2009-02-19 | 개시 | Canaccord Adams | Buy |
| 2008-07-07 | 다운그레이드 | Wachovia | Outperform → Mkt Perform |
모두보기
Orthofix Medical Inc 주식(OFIX)의 최신 뉴스
Orthofix president Patrick Fisher sells $13,066 in stock By Investing.com - Investing.com India
Orthofix (OFIX) insider sale tied to RSU tax withholding - Stock Titan
Orthofix (OFIX) Stock: Finishes 3.62% Up at $10.59 on the Day; Price Setup: the Supplied Trading Band Runs From $10.06 to $11.12 under the Current SnapshotExtension Target - Vinanet
Juniper investment sells $402,744 in Orthofix Medical shares By Investing.com - Investing.com
Orthofix Medical (NASDAQ: OFIX) logs new insider trades - Stock Titan
Juniper Investment Company reports Orthofix Medical share disposal worth $402,483.1 - Bitget
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook - marketbeat.com
Armistice Capital (OFIX) discloses 3.26M-share, 8.01% Orthofix Medical stake - Stock Titan
Orthofix Medical (OFIX) Slips 2.1% to $10.18 as Traders Eye Support ZoneTriple Bottom - Vinanet
Orthofix Medical Inc. (DE) Share Price Live Today – NASDAQ:OFIX Stock Price, Chart, News, History - Upstox
OFIX 1H 2026: Limb Recon Leads, Spine Gains Traction, Europe’s Plot Twist - Orthopedics This Week
Orthofix at Canaccord Genuity conference: turnaround gains face spine test By Investing.com - Investing.com South Africa
Orthofix at Canaccord Genuity conference: turnaround gains face spine test - Investing.com
OFIX Q2 2026 Earnings: Narrower-Than-Expected Loss of -$0.39 Beats Estimates, Shares Edge LowerOperating Margin Analysis - Vinanet
(OFIX) Risk Channels and Responsive Allocation - Stock Traders Daily
Analysts Have Conflicting Sentiments on These Healthcare Companies: Orthofix Medical (OFIX), Rhythm Pharmaceuticals (RYTM) and Viatris (VTRS) - The Globe and Mail
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Cuts Target Price to $13 - Moomoo
OFIX Maintains Buy Rating -- Price Target Lowered to $13.00 by C - GuruFocus
Orthofix Medical (NASDAQ:OFIX) Price Target Lowered to $13.00 at Canaccord Genuity Group - marketbeat.com
Dimensional Fund Advisors LP Trims Stock Holdings in Orthofix Medical Inc. $OFIX - MarketBeat
Orthofix Medical (OFIX) Holds Near $10.26 as Support at $9.75 Comes into FocusKAMA Signal - Vinanet
Orthofix Medical Inc. (OFIX): Analyzing the 34.43% Potential Upside in the Medical Devices Sector - directorstalkinterviews.com
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Orthofix Medical (OFIX) Stock Sinks As One Off Growth Clouds Outlook - Sahm
Is Orthofix Medical Inc (OFIX) Positioning for Growth After Q2 E - GuruFocus
Orthofix Medical Inc (OFIX) (Q2 2026) Earnings Call Highlights: - GuruFocus
Earnings call transcript: Orthofix tops Q2 2026 estimates, lifts outlook By Investing.com - Investing.com Canada
Earnings call transcript: Orthofix tops Q2 2026 estimates, lifts outlook - Investing.com
Orthofix Medical (NASDAQ:OFIX) Issues Quarterly Earnings Results - MarketBeat
Orthofix Medical Q2 Earnings Call Highlights - TradingView
Orthofix Medical Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Orthofix Medical drops despite Q2 beats - Seeking Alpha
Orthofix Medical Announces Q2 2026 Financial Results and Non-GAAP Metrics in SEC Filing - Kalkine Media
Orthofix Medical Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:OFIX) 2026-08-05 - Seeking Alpha
Orthofix Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
OFIX: Q2 delivered 5% sales growth and improved outlook, but small U.S. spine distributor weakness persists - TradingView
Orthofix Medical Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Orthofix (OFIX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
OFIX: Q2 2026 net sales up 4% to $210.9M; full-year guidance raised after Medicare reimbursement restored - TradingView
Orthofix: Q2 Earnings Snapshot - marketscreener.com
Orthofix Medical Inc. Q2 2026: Revenue $210.9M, EPS $(0.39) — 10-Q Summary - TradingView
[10-Q] Orthofix Medical Inc. Quarterly Earnings Report - Stock Titan
OFIX: Q2 2026 net sales rose 5% YoY, with strong growth in Spine Fixation and Limb Reconstruction - TradingView
BRIEF-Orthofix Medical Q2 Sales USD 210.9 Million Vs. IBES Estimate USD 209.3 Million - TradingView
Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress - Business Wire
Orthofix Medical Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Orthofix Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Orthofix Medical Inc (OFIX) Institutional Confidence - TradingKey
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Orthofix Medical Inc (OFIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Orthofix Medical Inc 주식 (OFIX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| McPherron Aviva | Pres, Global Ops & Qual |
Jun 18 '26 |
Sale |
9.38 |
3,670 |
34,425 |
66,330 |
| HENNEMAN JOHN B III | Director |
May 07 '26 |
Buy |
12.26 |
5,000 |
61,295 |
90,809 |
| Engine Capital Management, LP | 10% Owner |
May 05 '26 |
Buy |
11.99 |
112,950 |
1,354,587 |
3,783,131 |
| Engine Capital Management, LP | 10% Owner |
May 06 '26 |
Buy |
12.23 |
41,946 |
512,916 |
3,821,285 |
| Engine Capital Management, LP | 10% Owner |
May 07 '26 |
Buy |
12.18 |
30,000 |
365,425 |
3,848,573 |
| Cedron Jorge Andres | CLO |
Apr 16 '26 |
Sale |
12.82 |
3,743 |
47,985 |
59,006 |
| Vitale Lucas | CP&BOO |
Mar 17 '26 |
Sale |
11.92 |
4,269 |
50,886 |
160,449 |
| CAPPS VICKIE L | Director |
Mar 09 '26 |
Buy |
12.48 |
2,500 |
31,200 |
25,085 |
| CAPPS VICKIE L | Director |
Mar 10 '26 |
Buy |
12.45 |
2,500 |
31,124 |
27,585 |
| Andrews Julie | CFO |
Mar 04 '26 |
Sale |
12.92 |
2,425 |
31,322 |
91,109 |
0.32%
0.15%
자본화:
|
볼륨(24시간):